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Introduction
New non-vitamin K Target Specific Oral Anticoagulants
(TSOACs) have a favourable risk-benefit profile and debat-
able cost effectiveness. Large numbers and data from multi-
ple countries in a European study are required to investigate
safety issue of TSOACs in subgroups, e.g. people with an
intracranial haemorrhage.
Objectives and Approach
We developed an approach to rapidly replicate data and anal-
yses to support cross-country distributed research within the
UK/EU using Electronic Health Records (EHRs). This project
was conceptualised and initialled by linking relevant datasets
held in multiple data warehouses, in Scotland with the Scottish
National Data Safe Haven, and in Wales through the Secure
Anonymised Information Linkage (SAIL) databank. Analysts
in Edinburgh and Swansea had remote access to each other’s
datasets and worked collaboratively to harmonise variables and
analysis scripts. . A common R code script has been produced
to harmonise individual data as well as the outputs from the
study.
Results
The study screened data on 8M people to develop a cohort
that included pseudonymised information of 4,153 individuals
in Scotland and 2,676 individuals in Wales, 6,829 individuals in
total. Standardised risk analyses were completed in both set-
tings with ongoing work in combining the analyses. In Wales,
39.5% of the patients in the cohort had been admitted to hos-
pitals due to serious vascular events or died caused by these
events, after intracranial haemorrhage. Incident rates for male
and female are 0.63 and 0.7 respectively. Within the cohort,
0.5% were prescribed with TSOACs and 3% with Warfarin
(included as reference). The project is also in the process of
including other European jurisdictions.
Conclusion/Implications
The adopted approach was the simplest, yet most efficient and
cost-effective method to ensure consistency in analysis and co-
herence with currently available governance systems of both
safe havens. It can also be considered as an initialisation of de-
veloping infrastructure to support research using EHRs across
the UK and EU.
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